Izraelis - hebrajų - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

Izraelis - hebrajų - Ministry of Health

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - קפסולות - mycophenolate mofetil 250 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

Izraelis - hebrajų - Ministry of Health

roche pharmaceuticals (israel) ltd - mycophenolate mofetil - טבליות מצופות פילם - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. cellcept should be used concomitantly with cyclosporin and corticosteroids.allogenic hepatic transplant.

Izraelis - hebrajų - Ministry of Health

rafa laboratories ltd - mycophenolate mofetil 500 mg - film coated tablets - mycophenolic acid - prophylaxis of rejection in renal allograft recipients, and in patients receiving allogenic cardiac transplants. allogenic hepatic transplant. mefetil should be used concomitantly with cyclosporin and corticosteroids.

Izraelis - hebrajų - Ministry of Health

rafa laboratories ltd - mycophenolate mofetil 250 mg - capsules - mycophenolic acid - prophylaxis of rejection in renal allograft recipients, and in patients receiving allogenic cardiac transplants. allogenic hepatic transplant. mefetil should be used concomitantly with cyclosporin and corticosteroids.

Izraelis - hebrajų - Ministry of Health

novartis israel ltd - basiliximab - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - basiliximab 20 mg/vial - basiliximab - basiliximab - prophylaxis of acute organ rejection in de novo renal transplantation in combination with cyclosporin and corticosteroid based immunosuppression

Izraelis - hebrajų - Ministry of Health

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Izraelis - hebrajų - Ministry of Health

novartis pharma services ag - mycophenolic acid 180 mg - film coated tablets - mycophenolic acid - myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

Izraelis - hebrajų - Ministry of Health

novartis pharma services ag - mycophenolic acid 360 mg - film coated tablets - mycophenolic acid - myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

Izraelis - hebrajų - Ministry of Health

teva israel ltd - mycophenolate mofetil - טבליה - mycophenolate mofetil 500 mg - mycophenolic acid - mycophenolic acid - prophylaxis of rejection in renal allograft recepients, in patients receiving allogenic cardiac transplants and in allogenic hepatic transplants. mycophenolate teva should be used concomitantly with ciclosporin and corticosteroids.